Solara Active Pharma Sciences (Solara) has delivered its best-ever quarterly performance. Results are ahead of estimates. Sales at Rs. 397.6 crore grew by 13% y-o-y, backed by 17% y-o-y growth in regulated markets. Other markets reported 3% growth. Operating profit margin (OPM) stood at 24.5%, expanding impressively by 518 bps y-o-y, aided by 450 bps expansion in gross margin due to favourable product mix. Operating profit at Rs. 97.6 crore was up 43.5% y-o-y. PAT for the quarter stood at Rs. 56.7 crore, up 96.2% y-o-y and was ahead of estimates. Solara has proven capabilities to manufacture complex/combination active pharmaceutical ingredients (APIs). There are immense opportunities that have opened up for API players such as Solara. The company is witnessing...